Live Breaking News & Updates on Aerovate Therapeutics Inc

Stay updated with breaking news from Aerovate therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aerovate Therapeutics (NASDAQ:AVTE) Stock Price Up 3.6%

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shot up 3.6% during mid-day trading on Thursday . The company traded as high as $24.05 and last traded at $23.86. 59,742 shares traded hands during trading, a decline of 62% from the average session volume of 159,164 shares. The stock had previously closed at $23.02. Wall […] ....

United States , Timothyp Noyes , Marinus Verwijs , Aerovate Therapeutics Inc , Wells Fargo Company , Jefferies Financial Group , Ikarian Capital , Securities Exchange Commission , Aerovate Therapeutics Company Profile , Vanguard Group Inc , Silverarc Capital Management , Swiss National Bank , Aerovate Therapeutics , Get Free Report , Exchange Commission , Point Capital , Capital Management , National Bank , Aerovate Therapeutics Daily ,

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Up 16.5% in May

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,190,000 shares, an increase of 16.5% from the April 30th total of 1,880,000 shares. Based on an average daily trading volume, of 167,500 shares, the short-interest […] ....

Switzerland General , United States , Benjamint Dake , Georgea Eldridge , Aerovate Therapeutics Inc , Eventide Asset Management , Alps Advisors Inc , Securities Exchange Commission , Wells Fargo Company , Swiss National Bank , Jefferies Financial Group , Aerovate Therapeutics Company Profile , Silverarc Capital Management , Aerovate Therapeutics , Get Free Report , Exchange Commission , Asset Management , National Bank , Capital Management , Vestal Point Capital , Financial Group , Wells Fargo , Aerovate Therapeutics Daily ,

Aerovate Therapeutics (NASDAQ:AVTE) Stock Rating Reaffirmed by Wedbush

Wedbush reiterated their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Wedbush currently has a $41.00 price target on the stock. Other analysts also recently issued reports about the stock. Jefferies Financial Group initiated coverage on shares of Aerovate Therapeutics in […] ....

Switzerland General , United States , Hunter Gillies , Georgea Eldridge , Silverarc Capital Management , Securities Exchange Commission , Aerovate Therapeutics Inc , Alps Advisors Inc , Wells Fargo Company , Eventide Asset Management , Jefferies Financial Group , Swiss National Bank , Aerovate Therapeutics , Free Report , Financial Group , Get Free Report , Exchange Commission , Asset Management , National Bank , Capital Management , Vestal Point Capital , Aerovate Therapeutics Daily ,

Wedbush Reiterates "Outperform" Rating for Aerovate Therapeutics (NASDAQ:AVTE)

Wedbush restated their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research report report published on Wednesday, Benzinga reports. The brokerage currently has a $41.00 price target on the stock. AVTE has been the subject of a number of other reports. Wells Fargo & Company reissued an overweight rating and […] ....

United States , Georgea Eldridge , Hunter Gillies , Eventide Asset Management , Jefferies Financial Group , Ikarian Capital , Aerovate Therapeutics Inc , Wells Fargo Company , Vanguard Group Inc , Alps Advisors Inc , Aerovate Therapeutics , Free Report , Financial Group , Therapeutics Stock Down , Get Free Report , Asset Management , Point Capital , Alps Advisors , Aerovate Therapeutics Daily ,